Phone Intervention Decreases ED Visits, Hospitalizations in Head and Neck Cancer
A phone intervention can decrease ED visits and hospital admissions in head and neck cancer patients receiving radiation therapy, a study suggests.
All articles by Jessica Nye, PhD
How Different Components of Palliative Care Services Affect End-of-Life Cancer Care
During end-of-life care, cancer patients who utilized spiritual, psychology, and social work services received different oncologic treatment.
Motixafortide Increases HSPC Mobilization in MM Patients
Adding motixafortide to G-CSF increases mobilization of CD34+ HSPCs in patients with multiple myeloma, a phase 3 trial suggests.
Camonsertib-PARP Inhibitor Combos May Meet Unmet Need in Advanced Solid Tumors
Combining camonsertib with PARP inhibitors may be an effective strategy for treating advanced solid tumors, a study suggests.
ALLO-316, a CAR T-Cell Therapy, Shows Activity in Advanced RCC
ALLO-316 has shown activity in a phase 1 study of patients with heavily pretreated, advanced clear cell renal cell carcinoma.
Petosemtamab Shows “Clinically Meaningful Activity” in Advanced HNSCC
Petosemtamab can produce durable responses in patients with advanced head and neck squamous cell carcinoma, a phase 1/2 study suggests.
REGN5459 Produces Durable Responses in Relapsed/Refractory Multiple Myeloma
REGN5459 appears safe and can produce durable responses in patients with relapsed or refractory multiple myeloma, a phase 1/2 study suggests.
Prehabilitation Prior to CRC Surgery Reduces Postoperative Complications
A prehabilitation intervention prior to colorectal cancer surgery decreased postoperative complication rates.
Lack of Data to Support ICI Retreatment in Advanced Melanoma
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it, a study suggests.
NCCN Classification May Predict Long-Term Outcomes in Localized Prostate Cancer
NCCN classification is associated with long-term outcomes in patients with localized prostate cancer, a new study suggests.
- Loading...
Loading...
Next post in NCCN 2023
Loading... 
Loading...